annual CAPEX:
$78.40M+$889.00K(+1.15%)Summary
- As of today (June 10, 2025), ABCL annual capital expenditures is $78.40 million, with the most recent change of +$889.00 thousand (+1.15%) on December 31, 2024.
- During the last 3 years, ABCL annual CAPEX has risen by +$19.94 million (+34.12%).
- ABCL annual CAPEX is now at all-time high.
Performance
ABCL CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$10.64M-$4.99M(-31.95%)Summary
- As of today (June 10, 2025), ABCL quarterly capital expenditures is $10.64 million, with the most recent change of -$4.99 million (-31.95%) on March 31, 2025.
- Over the past year, ABCL quarterly CAPEX has dropped by -$13.50 million (-55.94%).
- ABCL quarterly CAPEX is now -71.10% below its all-time high of $36.80 million, reached on June 30, 2021.
Performance
ABCL quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$64.89M-$13.50M(-17.23%)Summary
- As of today (June 10, 2025), ABCL TTM capital expenditures is $64.89 million, with the most recent change of -$13.50 million (-17.23%) on March 31, 2025.
- Over the past year, ABCL TTM CAPEX has dropped by -$21.77 million (-25.12%).
- ABCL TTM CAPEX is now -25.12% below its all-time high of $86.66 million, reached on March 31, 2024.
Performance
ABCL TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ABCL CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.1% | -55.9% | -25.1% |
| 3 y3 years | +34.1% | -26.6% | -6.4% |
| 5 y5 years | +1861.4% | +90.5% | +1062.3% |
ABCL CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +34.1% | -66.0% | at low | -25.1% | +1.7% |
| 5 y | 5-year | at high | +1861.4% | -71.1% | +608.1% | -25.1% | +1062.3% |
| alltime | all time | at high | +1861.4% | -71.1% | +608.1% | -25.1% | +1062.3% |
ABCL CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $10.64M(-32.0%) | $64.89M(-17.2%) |
| Dec 2024 | $78.40M(+1.1%) | $15.63M(-15.6%) | $78.40M(+0.8%) |
| Sep 2024 | - | $18.52M(-7.9%) | $77.76M(-2.3%) |
| Jun 2024 | - | $20.11M(-16.7%) | $79.57M(-8.2%) |
| Mar 2024 | - | $24.14M(+61.0%) | $86.66M(+11.8%) |
| Dec 2023 | $77.51M(+6.7%) | $14.99M(-26.3%) | $77.51M(+3.6%) |
| Sep 2023 | - | $20.33M(-25.3%) | $74.85M(+8.4%) |
| Jun 2023 | - | $27.20M(+81.5%) | $69.03M(-5.6%) |
| Mar 2023 | - | $14.98M(+21.5%) | $73.15M(+0.7%) |
| Dec 2022 | $72.66M | $12.33M(-15.0%) | $72.66M(+4.2%) |
| Sep 2022 | - | $14.51M(-53.7%) | $69.76M(+9.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $31.32M(+116.1%) | $63.82M(-7.9%) |
| Mar 2022 | - | $14.49M(+53.7%) | $69.30M(+18.6%) |
| Dec 2021 | $58.45M(+298.4%) | $9.43M(+10.0%) | $58.45M(+15.7%) |
| Sep 2021 | - | $8.57M(-76.7%) | $50.52M(+10.2%) |
| Jun 2021 | - | $36.80M(+910.0%) | $45.84M(+259.9%) |
| Mar 2021 | - | $3.64M(+142.6%) | $12.73M(-13.2%) |
| Dec 2020 | $14.67M(+267.1%) | $1.50M(-61.3%) | $14.67M(+11.4%) |
| Sep 2020 | - | $3.88M(+4.9%) | $13.17M(+41.8%) |
| Jun 2020 | - | $3.70M(-33.7%) | $9.29M(+66.3%) |
| Mar 2020 | - | $5.58M | $5.58M |
| Dec 2019 | $4.00M(-24.7%) | - | - |
| Dec 2018 | $5.31M | - | - |
FAQ
- What is AbCellera Biologics annual capital expenditures?
- What is the all time high annual CAPEX for AbCellera Biologics?
- What is AbCellera Biologics annual CAPEX year-on-year change?
- What is AbCellera Biologics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for AbCellera Biologics?
- What is AbCellera Biologics quarterly CAPEX year-on-year change?
- What is AbCellera Biologics TTM capital expenditures?
- What is the all time high TTM CAPEX for AbCellera Biologics?
- What is AbCellera Biologics TTM CAPEX year-on-year change?
What is AbCellera Biologics annual capital expenditures?
The current annual CAPEX of ABCL is $78.40M
What is the all time high annual CAPEX for AbCellera Biologics?
AbCellera Biologics all-time high annual capital expenditures is $78.40M
What is AbCellera Biologics annual CAPEX year-on-year change?
Over the past year, ABCL annual capital expenditures has changed by +$889.00K (+1.15%)
What is AbCellera Biologics quarterly capital expenditures?
The current quarterly CAPEX of ABCL is $10.64M
What is the all time high quarterly CAPEX for AbCellera Biologics?
AbCellera Biologics all-time high quarterly capital expenditures is $36.80M
What is AbCellera Biologics quarterly CAPEX year-on-year change?
Over the past year, ABCL quarterly capital expenditures has changed by -$13.50M (-55.94%)
What is AbCellera Biologics TTM capital expenditures?
The current TTM CAPEX of ABCL is $64.89M
What is the all time high TTM CAPEX for AbCellera Biologics?
AbCellera Biologics all-time high TTM capital expenditures is $86.66M
What is AbCellera Biologics TTM CAPEX year-on-year change?
Over the past year, ABCL TTM capital expenditures has changed by -$21.77M (-25.12%)